Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Electrostimulation of the posterior tibial nerve in individuals with overactive bladder: a literature review.

Garcia MBS, Pereira JS.

J Phys Ther Sci. 2018 Oct;30(10):1333-1340. doi: 10.1589/jpts.30.1333. Epub 2018 Oct 12. Review.

2.

Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.

Barroso U Jr, Viterbo W, Bittencourt J, Farias T, Lordêlo P.

J Urol. 2013 Aug;190(2):673-7. doi: 10.1016/j.juro.2013.02.034. Epub 2013 Feb 16.

PMID:
23422257
3.

Treatments for overactive bladder: focus on pharmacotherapy.

Geoffrion R; UROGYNAECOLOGY COMMITTEE.

J Obstet Gynaecol Can. 2012 Nov;34(11):1092-1101. doi: 10.1016/S1701-2163(16)35440-8.

PMID:
23231848
4.

Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.

Amarenco G, Ismael SS, Even-Schneider A, Raibaut P, Demaille-Wlodyka S, Parratte B, Kerdraon J.

J Urol. 2003 Jun;169(6):2210-5.

PMID:
12771752
5.

Management of refractory overactive bladder in children by transcutaneous posterior tibial nerve stimulation: A controlled study.

Boudaoud N, Binet A, Line A, Chaouadi D, Jolly C, Fiquet CF, Ripert T, Merol ML.

J Pediatr Urol. 2015 Jun;11(3):138.e1-10. doi: 10.1016/j.jpurol.2014.09.013. Epub 2015 Mar 31.

PMID:
25979217
6.

[Tibial nerve transcutaneous stimulation for refractory idiopathic overactive bladder in children and adolescents].

Bouali O, Even L, Mouttalib S, Moscovici J, Galinier P, Game X.

Prog Urol. 2015 Sep;25(11):665-72. doi: 10.1016/j.purol.2015.04.005. Epub 2015 May 26. French.

PMID:
26022237
7.

Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.

Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, Macdiarmid SA.

J Urol. 2010 Apr;183(4):1438-43. doi: 10.1016/j.juro.2009.12.036. Epub 2010 Feb 20.

PMID:
20171677
8.

Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report.

Patidar N, Mittal V, Kumar M, Sureka SK, Arora S, Ansari MS.

J Pediatr Urol. 2015 Dec;11(6):351.e1-6. doi: 10.1016/j.jpurol.2015.04.040. Epub 2015 Jul 29.

PMID:
26279104
9.

[Physiotherapy and neurogenic lower urinary tract dysfunction in multiple sclerosis patients: a randomized controlled trial].

Gaspard L, Tombal B, Opsomer RJ, Castille Y, Van Pesch V, Detrembleur C.

Prog Urol. 2014 Sep;24(11):697-707. doi: 10.1016/j.purol.2014.05.003. Epub 2014 Jun 19. French.

PMID:
25214451
10.

[Posterior tibial nerve stimulation in the management of overactive bladder: a prospective and controlled study].

Bellette PO, Rodrigues-Palma PC, Hermann V, Riccetto C, Bigozzi M, Olivares JM.

Actas Urol Esp. 2009 Jan;33(1):58-63. Spanish.

PMID:
19462726
11.

Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study.

de Sèze M, Raibaut P, Gallien P, Even-Schneider A, Denys P, Bonniaud V, Gamé X, Amarenco G.

Neurourol Urodyn. 2011 Mar;30(3):306-11. doi: 10.1002/nau.20958. Epub 2011 Feb 8.

PMID:
21305588
12.

Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.

Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA.

J Urol. 2013 Jun;189(6):2194-201. doi: 10.1016/j.juro.2012.11.175. Epub 2012 Dec 3.

PMID:
23219541
13.

Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives.

Janssen DA, Martens FM, de Wall LL, van Breda HM, Heesakkers JP.

Med Devices (Auckl). 2017 Jun 1;10:109-122. doi: 10.2147/MDER.S115678. eCollection 2017. Review.

14.

[Transcutaneous tibial nerve stimulation in the overactive bladder syndrome in patients with Parkinson's syndromes].

Ohannessian A, Kaboré FA, Agostini A, Lenne Aurier K, Witjas T, Azulay JP, Karsenty G.

Prog Urol. 2013 Sep;23(11):936-9. doi: 10.1016/j.purol.2013.07.004. Epub 2013 Aug 6. French.

PMID:
24010924
15.

Non-invasive transcutaneous electrical stimulation in the treatment of overactive bladder.

Slovak M, Chapple CR, Barker AT.

Asian J Urol. 2015 Apr;2(2):92-101. doi: 10.1016/j.ajur.2015.04.013. Epub 2015 Apr 16. Review.

16.

Neuromodulative treatment of overactive bladder--noninvasive tibial nerve stimulation.

Svihra J, Kurca E, Luptak J, Kliment J.

Bratisl Lek Listy. 2002;103(12):480-3.

PMID:
12696778
17.

[Outcomes of transcutaneous posterior tibial nerve stimulation for overactive bladder in diabetic patients].

Mathieu L, Peyronnet B, Senal N, Fontaine S, Manunta A, Honoré T, Hascoet J, Damphousse M, Bonan I, Kerdraon J.

Prog Urol. 2017 Dec;27(17):1091-1097. doi: 10.1016/j.purol.2017.08.006. Epub 2017 Sep 28. French.

PMID:
28964687
18.

Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.

Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, Siegel SW, Tate SB, Jarnagin BK, Rosenblatt PL, Feagins BA.

J Urol. 2009 Sep;182(3):1055-61. doi: 10.1016/j.juro.2009.05.045. Epub 2009 Jul 18.

PMID:
19616802
19.

Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation.

Martinson M, MacDiarmid S, Black E.

J Urol. 2013 Jan;189(1):210-6. doi: 10.1016/j.juro.2012.08.085. Epub 2012 Nov 20. Erratum in: J Urol. 2013 Sep;190(3):1142.

PMID:
23174264
20.

Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder.

Chen HW, Bercik RS, Werner EF, Thung SF.

J Urol. 2012 Jan;187(1):178-84. doi: 10.1016/j.juro.2011.09.052. Epub 2011 Nov 17.

PMID:
22100006

Supplemental Content

Support Center